Evidence map›Paper›PMID 40979870›Full record

ArticleChemical science2025

Multifaceted photocatalysis enables cobalt catalyzed enantioselective C-H activation and APEX reaction for C-N axially chiral molecules.

Mainak Koner, Nityananda Ballav, Anirudh J Varma, Suman Ghosh, Tuhin Mondal, Rositha Kuniyil, Mahiuddin Baidya

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Chemical science · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mainak KonerDepartment of Chemistry, Indian Institute of Technology Madras Chennai 600036 India mbaidya@iitm.ac.in.
Nityananda BallavDepartment of Chemistry, Indian Institute of Technology Madras Chennai 600036 India mbaidya@iitm.ac.in.
Anirudh J VarmaDepartment of Chemistry, Indian Institute of Technology Palakkad Palakkad 678623 Kerala India.
Suman GhoshDepartment of Chemistry, Indian Institute of Technology Madras Chennai 600036 India mbaidya@iitm.ac.in.
Tuhin MondalDepartment of Chemistry, Indian Institute of Technology Madras Chennai 600036 India mbaidya@iitm.ac.in.
Rositha KuniyilDepartment of Chemistry, Indian Institute of Technology Palakkad Palakkad 678623 Kerala India.ORCID https://orcid.org/0000-0001-5480-3667
Mahiuddin BaidyaDepartment of Chemistry, Indian Institute of Technology Madras Chennai 600036 India mbaidya@iitm.ac.in.ORCID https://orcid.org/0000-0001-9415-7137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecules with the C-N stereogenic axes have widespread applications, yet their asymmetric synthesis under mild and environmentally friendly conditions is becoming increasingly challenging. Herein, we report the merger of inexpensive photoredox catalysis with a cobalt-catalyzed asymmetric C-H activation/APEX strategy, enabling cascade annulation of (hetero)arenes and alkenes with α-aryl-allenyl acetates to deliver C-N axially chiral benzophenanthridinone and polycyclic quinolinone frameworks with very high yields and enantioselectivities at room temperature. This methodology leverages the multifaceted role of photocatalysis - facilitating the redox event of the cobalt catalyst and the formation of key intermediates that drive the APEX process. It also harnesses the α-aryl-allenyl acetate coupling partners as the formal arene precursors, which have been elusive thus far. The intricacy of the reaction mechanism and the rationale behind the stereoselective outcomes were also unraveled through controlled experiments and DFT studies.

Identifiers

PMID40979870
PMCPMC12447758

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.